SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-341283
Filing Date
2021-11-26
Accepted
2021-11-26 16:45:55
Documents
12
Period of Report
2021-11-26
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d260834d8k.htm   iXBRL 8-K 22030
  Complete submission text file 0001193125-21-341283.txt   143581

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avir-20211126.xsd EX-101.SCH 2898
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avir-20211126_lab.xml EX-101.LAB 18123
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avir-20211126_pre.xml EX-101.PRE 11409
5 EXTRACTED XBRL INSTANCE DOCUMENT d260834d8k_htm.xml XML 3350
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39661 | Film No.: 211452122
SIC: 2834 Pharmaceutical Preparations